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Abstract
The authors have collaborated with many colleagues in several countries in formulating a useful and practical 
clinical tool for evaluating oral mucosal findings on routine examination. 
Consideration of several factors including history, evolution of positive findings and clinical information allows 
placement of examination results into one of three categories which are graded by a color scheme along a spec-
trum of concerns (green to red, or no concern to serious concern). Afforded to the clinician is a straightforward 
grading system as a starting point for office end clinic use for all patients.
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The use of information technology in the area of clinical 
decision making is an increasing paradigm in the prac-
tice of medicine and dentistry. The technologies at hand 
within clinical decision support systems (CDSSs) have 
the potential to reduce clinical errors by incorporating 
systems for data analysis with that analysis used to mea-
sure and prevent adverse clinical outcomes, ultimately 
resulting in improved overall quality and efficiency 
in the delivery of care (1,2). Evidence-based medici-
ne (EBM) - the practice of medicine based on the best 
available scientific evidence - can also improve clinical 
outcomes. The use of CDSSs to facilitate EBM there-
fore promises a substantial improvement in healthcare 
quality (3). EBM is based upon the scientific literatu-
re as the prime source of evidence, but should often be 
complemented by local, practice-based evidence for 
individual and site-specific clinical decision-making. 
However, lower levels of evidence and other sources 
such as Internet-based information should not be igno-
red (4). As stated recently in another context, “eviden-
ce-based recommendations are not a substitute for cli-
nical judgment, and decisions about care must carefully 
consider and incorporate the clinical characteristics and 
circumstances of each individual patient” (5).
Early diagnosis remains the essential aim of the primary 
care clinician as the single-most important contribution 
to help avoid the need for major and possibly radical 
treatment and thus improving chances of cure and re-
tention of function and quality of life. 
We have therefore produced an “expert system” regar-
ding evaluation of potentially malignant oral mucosal 
disease based upon considerable clinical experience on 
two continents, with advice from senior experienced 
colleagues. This was done in an effort to assist primary 
care clinicians in decision-making in relation to the 
identification and management of patients with possi-
ble oral cancer, based, in part on the previously publis-
hed “RULE” for oral cancer diagnosis (lesions that are 
Red or white; Ulcerated; Lump; Extending >3 weeks) 
(6). This tool is based on the grading of general clini-
cal observations along the green to red spectrum by the 
examining dental professional that should allow a de-
gree of confidence within an office or clinic setting for 
identification of signs and habits related to oral cancer 
causation and evolution (Table 1). The straightforward 
tool or scheme we have developed, addresses essential 
considerations in measurement, recognition and pre-
vention of oral cancer development and progression and 
the role played by the dental professional in recognition 
and appreciation of the historic and clinical factors in 
an all too common disease. Deviations from recognized 
clinical norms therefore, with either referral or direct 
action on the part of clinicians, thus can provide the best 
chance for reducing the frequency of errors and corres-
ponding improvement of treatment outcomes. Finally, 
this approach could serve as a working template for all 
initial and future oral examinations, even in the absence 
of prior clinical indicators of mucosal abnormalities.
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Table 1. Oral mucosal lesions symptoms and signs.
Issue No serious concern Concern: consider referral to specialist if 
clinician or patient concerned, especially if 
multiple isssues apply 
Serious concern; referral to specialist 
HISTORICAL 
FEATURES 
SIZE:  no change 
 
- No reduction in size, even after eliminating 
trauma to lesion after 10-14 days 
- Increasing size, even after eliminating 
trauma to lesion after 10-14 days 
CHRONOLOGY: lesion 
heals 
 
- No resolution over brief observation period - Rapid symptom onset  
- Solitary lesion or change in one area of 
lesion 
- Lesion persistent  3 weeks 
- Persistent ulceration 
- Persistent swelling 
- Loosening of a tooth  
- Non-healing tooth extraction socket 
NEUROLOGICAL: none 
 
- Lack of pain 
 
- Pain 
- Dysphagia 
- Odynophagia 
- Otalgia 
- Numbness/ paresthesia 
- Speech or voice change 
WEIGHT: normal                             -       No weight loss - Weight loss 
HISTORY LIFESTYLE HABITS: 
none 
         
- Tobacco consumption mild/moderate 
-  Betel quid or khat consumption mild/moderate 
- Alcohol consumption mild/moderate 
- Marijuana consumption mild/moderate 
- UV light exposure mild/moderate (lip surface 
exposure)  
- Late onset sexual debut 
- Few or moderate numbers of lifetime sexual 
partners  
- Tobacco consumption high 
-  Betel quid or khat consumption high 
- Alcohol consumption high 
- Marijuana consumption mild/moderate 
- UV light exposure high 
- Early sexual debut 
- Numerous lifetime sexual partners  
 
 
 MEDICAL HISTORY: 
Clear                       -         
- Deficiencies of iron, vitamin A, E or C 
- Diabetes 
- Discoid lupus erythematosus 
- Dyskeratosis congenita 
- Epidermolysis bullosa 
- Fanconi anaemia 
- High risk human papilloma virus infection 
- Immune defects; including HIV/AIDS, chronic 
candidosis 
- Medications: immunosuppressives, 
antihypertensives 
- Periodontitis, poor hygiene 
- Plummer-Vinson syndrome 
- Scleroderma 
- Xeroderma pigmentosum 
- Deficiencies of iron, vitamin A, E or C 
- Diabetes 
- Discoid lupus erythematosus 
- Dyskeratosis congenita 
- Epidermolysis bullosa 
- Fanconi anaemia 
- High risk human papilloma virus infection 
- Immune defects; including HIV/AIDS, 
chronic candidosis 
- Medications: immunosuppressives, 
antihypertensives 
- Periodontitis, poor hygiene 
- Plummer-Vinson syndrome 
- Scleroderma 
- Xeroderma pigmentosum 
EXAMINATION 
AND IMAGING 
POTENTIALLY 
MALIGNANT 
DISORDERS: none 
- Leukoplakia  
- Lichen planus/lichenoid mucositis 
- Oral submucous fibrosis 
- Erythroplakia 
- Leukoplakia; speckled or verrucous  
- Lichen planus/lichenoid mucositis; 
- unilateral  
LESION FEATURES; 
equivocal 
- White patch / (leukoplakia)  
- Lichen/lichenoid 
- Oral submucous fibrosis 
- Red patch (erythroplakia) 
- Mixed red and white patch 
(erythroleukoplakia/speckled  leukoplakia) 
- Granular surface  
- Rolled, elevated margins 
- Ulceration  
- Induration 
CERVICAL  LYMPH 
NODES; 
no enlargement 
- Possible enlargement - Enlarged , firm, fixed, non-tender, 
asymmetric 
IMAGING; no abnormality - Any bone density change - Poorly defined, un- corticated, irregular 
radiolucency 
- Lamina dura loss  
- Teeth displaced, and/or resorbed  
- Pathological fracture   
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